| [1] |
Burbridge S, Stewart I, Placzek M. Development of the neuroendocrine hypothalamus[J]. Compr Physiol, 2016, 6(2): 623-643.
|
| [2] |
Asa SL, Ezzat S. Hypothalamic hormone-producing tumors[J]. Handb Clin Neurol, 2021, 181: 67-74.
|
| [3] |
Asa SL, Mete O. Hypothalamic endocrine tumors: an update[J]. J Clin Med, 2019, 8(10): 1741.
|
| [4] |
Lopes MB, Sloan E, Polder J. Mixed gangliocytoma-pituitary adenoma: insights on the pathogenesis of a rare sellar tumor[J]. Am J Surg Pathol, 2017, 41(5): 586-595.
|
| [5] |
Quiroga-Padilla PJ, González-Devia D, Andrade R, et al. Sellar gangliocytoma: case report and review of an extremely rare tumour[J]. Case Rep Neurol, 2021, 13(2): 475-482.
|
| [6] |
Donadille B, Villa C, Gaillard S, et al. Gangliocytoma: outcome of a rare silent pituitary tumour[J]. BMJ Case Rep, 2017: bcr2016218859.
|
| [7] |
Asa SL, Ezzat S. An update on pituitary neuroendocrine tumors leading to acromegaly and gigantism[J]. J Clin Med, 2021, 10(11): 2254.
|
| [8] |
Asa S, Ezzat S, Kelly D, et al. Hypothalamic vasopressin-producing tumors: often inappropriate diuresis but occasionally cushing disease[J]. Am J Surg Path, 2019, 43(2): 251-260.
|
| [9] |
Roper J, O’Carroll A, Young W, et al. The vasopressin Avpr1b receptor: molecular and pharmacological studies[J]. Stress, 2011, 14(1): 98-115.
|
| [10] |
Myung JK, Cho HJ, Park CK, et al. Clinicopathological and genetic characteristics of extraventricular neurocytomas[J]. Neuropathology, 2013, 33(2): 111-121.
|
| [11] |
Vincent JL, Su F. Physiology and pathophysiology of the vasopressinergic system[J]. Best Pract Res Clin Anaesthesiol, 2008, 22(2): 243-252.
|
| [12] |
Nakamura K, Kimura S, Yamazaki M, et al. Immunohistochemical analyses of thyroid-specific enhancer-binding protein in the fetal and adult rat hypothalami and pituitary glands[J]. Brain Res Dev Brain Res, 2001, 130(2): 159-166.
|
| [13] |
Zhang D, Kim SSR, Kelly DF, et al. Somatostatin receptor ligand therapy-a potential therapy for neurocytoma[J]. J Clin Endocrinol Metab, 2019, 104(6): 2395-2402.
|
| [14] |
Aihara Y, Chiba K, Eguchi S, et al. Pediatric optic pathway/hypothalamic glioma[J]. Neurol Med Chir (Tokyo), 2018, 58(1): 1-9.
|
| [15] |
Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis type 1[J]. Nat Rev Dis Primers, 2017, 3: 17004.
|
| [16] |
Aslan IR, Cheung CC. Early and late endocrine effects in pediatric central nervous system diseases[J]. J Pediatr Rehabil Med, 2014, 7(4): 281-294.
|
| [17] |
Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood[J]. Horm Res Paediatr, 2015, 83(4): 232-241.
|
| [18] |
Josefson J, Listernick R, Fangusaro JR, et al. Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors[J]. J Pediatr, 2011, 158(3): 433-436.
|
| [19] |
廖指仪,田永吉.儿童视路胶质瘤诊疗和远期预后的研究进展[J].中华神经外科杂志, 2021, 37(2): 202-205.
|
| [20] |
Cohen NT, Cross JH, Arzimanoglou A, et al. Hypothalamic hamartomas: evolving understanding and management[J]. Neurology, 2021, 97(18): 864-873.
|
| [21] |
Harrison VS, Oatman O, Kerrigan JF. Hypothalamic hamartoma with epilepsy: review of endocrine comorbidity[J]. Epilepsia, 2017, 58 Suppl 2(Suppl 2): 50-59.
|
| [22] |
Bourdillon P, Ferrand-Sorbet S, Apra C, et al. Surgical treatment of hypothalamic hamartomas[J]. Neurosurg Rev, 2021, 44(2): 753-762.
|
| [23] |
van Tonder L, Burn S, Iyer A, et al. Open resection of hypothalamic hamartomas for intractable epilepsy revisited, using intraoperative MRI[J]. Childs Nerv Syst, 2018, 34(9): 1663-1673.
|
| [24] |
Ferrand-Sorbets S, Fohlen M, Delalande O, et al. Seizure outcome and prognostic factors for surgical management of hypothalamic hamartomas in children[J]. Seizure, 2020, 75: 28-33.
|
| [25] |
Boerwinkle VL, Foldes ST, Torrisi SJ, et al. Subcentimeter epilepsy surgery targets by resting state functional magnetic resonance imaging can improve outcomes in hypothalamic hamartoma[J]. Epilepsia, 2018, 59(12): 2284-2295.
|
| [26] |
Cantas-Orsdemir S, Eugster EA. Update on central precocious puberty: from etiologies to outcomes[J]. Expert Rev Endocrinol Metab, 2019, 14(2): 123-130.
|
| [27] |
Patti G, Ibba A, Morana G, et al. Central diabetes insipidus in children: diagnosis and management[J]. Best Pract Res Clin Endocrinol Metab, 2020, 34(5): 101440.
|
| [28] |
Das KK, Joseph J, Singh AK, et al. Capsuloganglionic germinoma: a rare site for uncommon childhood tumor[J]. Asian J Neurosurg, 2018, 13(2): 492-495.
|
| [29] |
Ilcus C, Silaghi H, Georgescu CE, et al. Molecular pathology and targeted therapies for personalized management of central nervous system germinoma[J]. J Pers Med, 2021, 11(7): 661.
|